|
|
Gary S. Firestein
J Clin Invest. 2004;
114(4):471
doi:10.1172/JCI22651
Abstract |
Full text
| PDF
T
he etiology of autoimmunity in humans remains poorly defined, and animal models provide a unique opportunity to study potential autoimmune mechanisms. A novel model of autoimmune inflammatory arthritis results from a point mutation in the ζ-associated–protein of 70 kDa (ZAP-70), which causes abnormal thymic T cell selection and survival of autoreactive clones. Although the resulting clinical and pathologic abnormalities are clearly T cell–dependent, macrophage and fibroblast cytokines such as IL-1 and TNF-α are required for full expression of the disease. The studies of Hata et al. raise the intriguing possibility that traditional proinflammatory cytokine networks represent common effector mechanisms in inflammatory joint diseases such as rheumatoid arthritis. Hence, effective therapeutic interventions can target either unique etiologic pathways related to adaptive immune responses or shared terminal mechanisms.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(10)
| Title and authors |
Publication |
Year |
PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?
Christian Rommel, Montserrat Camps, Hong Ji
|
Nat Rev Immunol
|
2007 |
Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis
Berent Prakken, Salvatore Albani
|
Arthritis Rheum
|
2007 |
Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis
A. Price, J. C. Lockhart, W. R. Ferrell, W. Gsell, S. McLean, R. D. Sturrock
|
Arthritis Rheum
|
2007 |
T cell epitope–specific immune therapy for rheumatic diseases
Salvatore Albani, Berent Prakken
|
Arthritis Rheum
|
2006 |
Amelioration of Collagen-Induced Arthritis in Mice by a Saponin Fraction fromGleditsia sinensis.
Hou Li-Fei, Dai Yue, Wang Chan, Xia Yu-Feng
|
Pharmaceutical Biology
|
2006 |
The role of T cells in cutaneous autoimmune disease
Selwyn Chow, Carina Rizzo, Larisa Ravitskiy, Animesh A. Sinha
|
Autoimmunity
|
2005 |
Fc Receptors and Their Role in Immune Regulation and Autoimmunity
Toshiyuki Takai
|
J Clin Immunol
|
2005 |
A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo1
Wen-liang ZHOU, Jin-ming WU, Qing-li WU, Jun-xia WANG, Yu ZHOU, Ru ZHOU, Pei-lan HE, Xiao-yu LI, Yi-fu YANG, Yu ZHANG, Ying LI, Jian-ping ZUO
|
Acta Pharmacologica Sinica
|
2005 |
Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis
Gim Gee Teng, Anthony M Turkiewicz, Larry W Moreland
|
Expert Opin. Biol. Ther.
|
2005 |
Regulation of arthritis by p53: Critical role of adaptive immunity
Egle Šimelyte, Sanna Rosengren, David L. Boyle, Maripat Corr, Douglas R. Green, Gary S. Firestein
|
Arthritis Rheum
|
2005 |
|